Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
Gill R, Alanine A, Bourson A, Buttelmann B, Fischer G, Heitz MP, Kew JN, Levet-Trafit B, Lorez HP, Malherbe P, Miss MT, Mutel V, Pinard E, Roever S, Schmitt M, Trube G, Wybrecht R, Wyler R, Kemp JA.
Gill R, et al. Among authors: fischer g.
J Pharmacol Exp Ther. 2002 Sep;302(3):940-8. doi: 10.1124/jpet.102.034322.
J Pharmacol Exp Ther. 2002.
PMID: 12183650